1990 - US President's National Medal of Science "For his discoveries and leadership in combining basic chemical research and clinical medicine to achieve new treatments of diseases which have enhanced the quality of life and extended survival rates for countless people.", Presented by President Bush at a White House East Room Ceremony on November 13, 1990.
1986 - Priestley Medal, American Chemical Society (ACS)
1972 - Welch Award in Chemistry, Robert A. Welch Foundation
1967 - William H. Nichols Medal, American Chemical Society (ACS)
1960 - Perkin Medal, Society of Chemical Industry, American Section
1950 - Fellow of the American Association for the Advancement of Science (AAAS)
1948 - Member of the National Academy of Sciences
1941 - ACS Award in Pure Chemistry, American Chemical Society (ACS)
Karl Folkers mostly deals with Internal medicine, Endocrinology, Substance P, Stereochemistry and Biochemistry. The various areas that Karl Folkers examines in his Internal medicine study include Gastroenterology and Cardiology. His Endocrinology study frequently links to related topics such as Neurotensin.
His studies deal with areas such as Anatomy, Antagonist, Pharmacology and Stimulation as well as Substance P. The Stereochemistry study combines topics in areas such as Coenzyme Q – cytochrome c reductase and D-4-amino-3-Isoxazolidone. Biochemistry is frequently linked to Isolation in his study.
His primary areas of study are Internal medicine, Stereochemistry, Endocrinology, Biochemistry and Coenzyme Q – cytochrome c reductase. His biological study spans a wide range of topics, including Gastroenterology and Cardiology. His study in Stereochemistry is interdisciplinary in nature, drawing from both Amino acid and Organic chemistry.
He has researched Endocrinology in several fields, including Receptor and In vitro. His study in Cofactor, Enzyme, Mitochondrion, Vitamin B12 and Biosynthesis are all subfields of Biochemistry. Karl Folkers interconnects Antagonist and Pharmacology in the investigation of issues within Substance P.
Karl Folkers focuses on Internal medicine, Endocrinology, Coenzyme Q10, Substance P and Stereochemistry. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Surgery and Cardiology. His work on Receptor expands to the thematically related Endocrinology.
His Coenzyme Q10 research is multidisciplinary, relying on both Cancer, Coenzyme Q – cytochrome c reductase, Antioxidant, Immunology and Disease. His Substance P research incorporates themes from Antagonist, Pharmacology and Stimulation. The study incorporates disciplines such as Amino acid, Peptide synthesis and Biological activity in addition to Stereochemistry.
His primary scientific interests are in Internal medicine, Endocrinology, Substance P, Coenzyme Q10 and Pharmacology. His Internal medicine research includes elements of Gastroenterology and Cardiology. His Substance p antagonist research extends to Endocrinology, which is thematically connected.
His Substance P research incorporates themes from Antagonist and Stimulation. As a part of the same scientific family, Karl Folkers mostly works in the field of Coenzyme Q10, focusing on Chemotherapy and, on occasion, Opportunistic infection and Constitutional symptoms. As part of one scientific family, Karl Folkers deals mainly with the area of Pharmacology, narrowing it down to issues related to the Anesthesia, and often Galanin and Neuropeptide.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide.
Jan Bøler;Franz Enzmann;K. Folkers;C.Y. Bowers.
Biochemical and Biophysical Research Communications (1969)
Crystalline Vitamin B12.
Edward L. Rickes;Norman G. Brink;Frank R. Koniuszy;Thomas R. Wood.
A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig.
J. M. Lundberg;A. Saria;E. Brodin;S. Rosell.
Proceedings of the National Academy of Sciences of the United States of America (1983)
Lovastatin decreases coenzyme Q levels in humans.
Karl Folkers;Per Langsjoen;Richard Willis;Phillip Richardson.
Proceedings of the National Academy of Sciences of the United States of America (1990)
Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide
Cyril Y. Bowers;H.G. Friesen;P. Hwang;H.J. Guyda.
Biochemical and Biophysical Research Communications (1971)
A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation.
S. Leander;R. Håkanson;S. Rosell;K. Folkers.
Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10
Karl Folkers;Surasi Vadhanavikit;Svend A. Mortensen.
Proceedings of the National Academy of Sciences of the United States of America (1985)
Hydrogenolysis of Sulfur Compounds by Raney Nickel Catalyst
Ralph Mozingo;Donald E. Wolf;Stanton A. Harris;Karl Folkers.
Journal of the American Chemical Society (1943)
Biological evaluation of substance P antagonists.
K. Folkers;R. Håkanson;J. Hörig;Xu Jie-Cheng.
British Journal of Pharmacology (1984)
RESEARCHES ON PYRIMIDINES. CXXX. SYNTHESIS OF 2-KETO-1,2,3,4-TETRAHYDROPYRIMIDINES
Karl Folkers;H. J. Harwood;Treat B. Johnson.
Journal of the American Chemical Society (1932)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: